Publication | Closed Access

Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial

Gastrointestinal OncologyMedicineAdvanced Gastric CancerPharmacologyClinical TrialsPharmacotherapyCancer TreatmentOncology